£6.3M
Balderton Capital and Exor Ventures have led a seed round to help finance clinical trials and expand manufacturing capabilities.
SAVA Technologies develops wearable biosensors for continuous health monitoring.
SAVA Technologies develops wearable biosensors designed to track multiple biomarkers from beneath the skin. Its initial product provides an affordable continuous glucose monitoring solution for diabetes patients.
Renato Circi
Co-founder
Rafael Michali
Co-founder
Balderton Capital and Exor Ventures have led a seed round to help finance clinical trials and expand manufacturing capabilities.